Ferlin proteins in myoblast fusion and muscle growth

Por Posey, Avery D., Demonbreun, Alexis, McNally, Elizabeth M
Publicado no Curr Top Dev Biol (2011)

Expanding the Therapeutic Window for CAR T Cell Therapy in Solid Tumors: The Knowns and Unknowns of CAR T Cell Biology

Por Watanabe, Keisuke, Kuramitsu, Shunichiro, Posey, Avery D., June, Carl H.
Publicado no Front Immunol (2018)

Engineering and Design of Chimeric Antigen Receptors

Por Guedan, Sonia, Calderon, Hugo, Posey, Avery D., Maus, Marcela V.
Publicado no Mol Ther Methods Clin Dev (2018)

Generation and Validation of an Antibody to Canine CD19 for Diagnostic and Future Therapeutic Purposes

Por Preethi Haran, Kumudhini, Lockhart, Alexandra, Xiong, Ailian, Radaelli, Enrico, Savickas, Patrick J., Posey, Avery, Mason, Nicola J.
Publicado no Vet Pathol (2020)

Immunotherapy for Breast Cancer: Current and Future Strategies

Por Williams, Austin D., Payne, Kyle K., Posey, Avery D., Hill, Christine, Conejo-Garcia, Jose, June, Carl H., Tchou, Julia
Publicado no Curr Surg Rep (2017)

Myoferlin is required for insulin-like growth factor response and muscle growth

Por Demonbreun, Alexis R., Posey, Avery D., Heretis, Konstantina, Swaggart, Kayleigh A., Earley, Judy U., Pytel, Peter, McNally, Elizabeth M.
Publicado em 2010

Endocytic Recycling Proteins EHD1 and EHD2 Interact with Fer-1-like-5 (Fer1L5) and Mediate Myoblast Fusion

Por Posey, Avery D., Pytel, Peter, Gardikiotes, Konstantina, Demonbreun, Alexis R., Rainey, Mark, George, Manju, Band, Hamid, McNally, Elizabeth M.
Publicado em 2011

Enhancing T cell persistence of CAR-redirected T cells in solid tumors

Por Guedan, Sonia, McGettigan, Shannon E, Posey, Avery D, Lee, Jihyun, Kawalekar, Omkar, Patel, Prachi R, Keith, Brian, June, Carl
Publicado no J Immunother Cancer (2014)

Diversity Is a Strength of Cancer Research in the U.S.

Por Merad, Miriam, Posey, Avery D., Olivero, Ofelia, Singh, Pankaj K., Mouneimne, Ghassan, Li, Lingyin, Wallace, LaShanale M., Hayes, Tikvah K.
Publicado no Cancer Cell (2020)

The Endocytic Recycling Protein EHD2 Interacts with Myoferlin to Regulate Myoblast Fusion

Por Doherty, Katherine R., Demonbreun, Alexis R., Wallace, Gregory Q., Cave, Andrew, Posey, Avery D., Heretis, Konstantina, Pytel, Peter, McNally, Elizabeth M.
Publicado em 2008

Normal myoblast fusion requires myoferlin

Por Doherty, Katherine R., Cave, Andrew, Davis, Dawn Belt, Delmonte, Anthony J., Posey, Avery, Earley, Judy U., Hadhazy, Michele, McNally, Elizabeth M.
Publicado em 2005

Improving CART-Cell Therapy of Solid Tumors with Oncolytic Virus–Driven Production of a Bispecific T-cell Engager

Por Wing, Anna, Fajardo, Carlos Alberto, Posey, Avery D., Shaw, Carolyn, Da, Tong, Young, Regina M., Alemany, Ramon, June, Carl H., Guedan, Sonia
Publicado no Cancer Immunol Res (2018)

Single residue in CD28-costimulated CAR-T cells limits long-term persistence and antitumor durability

Por Guedan, Sonia, Madar, Aviv, Casado-Medrano, Victoria, Shaw, Carolyn, Wing, Anna, Liu, Fang, Young, Regina M., June, Carl H., Posey, Avery D.
Publicado no J Clin Invest (2020)

EHD1 mediates vesicle trafficking required for normal muscle growth and tubule development

Por Posey, Avery D., Swanson, Kaitlin E., Alvarez, Manuel G., Krishnan, Swathi, Earley, Judy E., Band, Hamid, Pytel, Peter, McNally, Elizabeth M., Demonbreun, Alexis R.
Publicado em 2014

ICOS-based chimeric antigen receptors program bipolar T(H)17/T(H)1 cells

Por Guedan, Sonia, Chen, Xi, Madar, Aviv, Carpenito, Carmine, McGettigan, Shannon E., Frigault, Matthew J., Lee, Jihyun, Posey, Avery D., Scholler, John, Scholler, Nathalie, Bonneau, Richard, June, Carl H.
Publicado em 2014

A cellular antidote to specifically deplete anti-CD19 chimeric antigen receptor–positive cells

Por Ruella, Marco, Barrett, David M., Shestova, Olga, Perazzelli, Jessica, Posey, Avery D., Hong, Seok Jae, Kozlowski, Miroslaw, Lacey, Simon F., Melenhorst, J. Joseph, June, Carl H., Gill, Saar I.
Publicado no Blood (2020)

Multiple cancer-specific antigens are targeted by a chimeric antigen receptor on a single cancer cell

Por He, Yanran, Schreiber, Karin, Wolf, Steven P., Wen, Frank, Steentoft, Catharina, Zerweck, Jonathan, Steiner, Madeline, Sharma, Preeti, Shepard, H. Michael, Posey, Avery, June, Carl H., Mandel, Ulla, Clausen, Henrik, Leisegang, Matthias, Meredith, Stephen C., Kranz, David M., Schreiber, Hans
Publicado no JCI Insight (2019)

Multiple cancer-specific antigens are targeted by a chimeric antigen receptor on a single cancer cell

Por He, Yanran, Schreiber, Karin, Wolf, Steven P., Wen, Frank, Steentoft, Catharina, Zerweck, Jonathan, Steiner, Madeline, Sharma, Preeti, Shepard, H. Michael, Posey, Avery, June, Carl H., Mandel, Ulla, Clausen, Henrik, Leisegang, Matthias, Meredith, Stephen C., Kranz, David M., Schreiber, Hans
Publicado no JCI Insight (2019)

Enhancing CAR T cell persistence through ICOS and 4-1BB costimulation

Por Guedan, Sonia, Posey, Avery D., Shaw, Carolyn, Wing, Anna, Da, Tong, Patel, Prachi R., McGettigan, Shannon E., Casado-Medrano, Victoria, Kawalekar, Omkar U., Uribe-Herranz, Mireia, Song, Decheng, Melenhorst, J. Joseph, Lacey, Simon F., Scholler, John, Keith, Brian, Young, Regina M., June, Carl H.
Publicado no JCI Insight (2018)

Identification of chimeric antigen receptors that mediate constitutive or inducible proliferation of T cells

Por Frigault, Matthew J, Lee, Jihyun, Basil, Maria Ciocca, Carpenito, Carmine, Motohashi, Shinichiro, Scholler, John, Kawalekar, Omkar U., Guedan, Sonia, McGettigan, Shannon E., Posey, Avery D., Ang, Sonny, Cooper, Laurence J. N., Platt, Jesse M., Johnson, F. Brad, Paulos, Chrystal M, Zhao, Yangbing, Kalos, Michael, Milone, Michael C., June, Carl H.
Publicado no Cancer Immunol Res (2015)